Skip to main content
YUHAN CORPORATION logo

YUHAN CORPORATION — Investor Relations & Filings

Ticker · 000100 ISIN · KR7000100008 KO Manufacturing
Open in API
Filings indexed 635 across all filing types
Latest filing 2025-10-31 Capital/Financing Update
Country KR South Korea
Listing KO 000100

About YUHAN CORPORATION

http://eng.yuhan.co.kr

Yuhan Corporation, established in 1926, is an integrated healthcare company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products. Its diverse portfolio encompasses prescription drugs, over-the-counter (OTC) medications, Active Pharmaceutical Ingredients (APIs), and intermediates for various therapeutic areas, including antibiotics and antivirals. The company also produces veterinary drugs and household goods. In addition to its own product lines, Yuhan operates as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive services to the pharmaceutical sector. Through its affiliates, the company is also involved in specialized areas such as nutrient infusion solutions.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항
Capital/Financing Update Classification · 95% confidence The document is a disclosure about a milestone payment related to a technology license agreement for a pharmaceutical product. It includes details about the milestone amount, the date of board resolution or fact confirmation, and references to previous similar disclosures. The document is short (1973 characters) and focuses on a specific business event rather than comprehensive financial data or detailed reports. It is an announcement of a significant business event relevant to investment decisions, which fits the category of 'Capital/Financing Update' (CAP) as it relates to a material financial milestone payment expected by the company. It is not an annual or interim report, audit, or earnings release, nor is it a regulatory filing or report publication announcement. Therefore, the best classification is CAP with high confidence.
2025-10-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about the ownership of securities by an executive named 김재용, including dates, share counts, and ownership percentages. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal ownership disclosure. This matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels. The document length is 2404 characters, which is consistent with a detailed ownership report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2025-10-27 Korean
투자판단관련주요경영사항
Capital/Financing Update Classification · 95% confidence The document is a brief announcement regarding a significant business decision related to the termination of a global license contract for a prostate cancer treatment. It includes details about the contract termination, financial terms, and the date of the board resolution. The document is short (768 characters) and focuses on a specific corporate action rather than comprehensive financial data or detailed reports. It fits the description of a Capital/Financing Update (CAP) as it relates to changes in contractual and financial obligations impacting the company's capital or financing arrangements.
2025-10-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It contains detailed information about the ownership of securities by an executive named 김열홍, including the number of shares owned, changes in ownership, and related dates. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange. This type of filing corresponds to a report of personal share transactions or holdings by company directors and executives, which matches the definition of 'Director's Dealing' (DIRS). The document length is 2405 characters, which is consistent with a detailed ownership report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is DIRS with high confidence.
2025-10-22 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 95% confidence The document is a disclosure about a regulatory approval for a pharmaceutical product (TrueSet AD-209) by the Korean Ministry of Food and Drug Safety (식품의약품안전처). It details clinical trial results, approval dates, and related information. The document is short (2353 characters) and focuses on a specific event related to investment judgment, not a financial report or earnings release. It is an announcement of a significant corporate event related to product approval, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like financial reports, management changes, or capital updates.
2025-09-30 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides the date, location, and purpose of the meeting, and explicitly states that the actual presentation materials will be posted on the company website at a later date. According to the 'Menu vs Meal' rule, this is an announcement of an event/report rather than the presentation itself, making it a Regulatory Filing (RNS) or a general announcement.
2025-09-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.